Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II open-label sonidegib study in basal cell carcinoma after prior Hedgehog inhibitor exposure
2012-004113-13Phase 2Completed
- Sponsor
- GZA
- Start
- Oct 2012
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sonidegib in basal cell carcinoma (BCC), sponsored by GZA. Started Oct 2012; status: completed.
02
Drugs
sonidegib
03
Conditions
basal cell carcinoma (BCC)
Beyond the preview
Go deeper on 2012-004113-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004113-13.